Viatris, Inc. (VTRS)
16.51
+0.17
(+1.04%)
USD |
NASDAQ |
Aug 31, 16:00
16.50
-0.01
(-0.06%)
After-Hours: 04:54
Viatris Net Income (TTM) : -410.70M for June 30, 2026
Net Income (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Net Income (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -410.70M |
| March 31, 2026 | -296.50M |
| December 31, 2025 | -3.515B |
| September 30, 2025 | -3.691B |
| June 30, 2025 | -3.468B |
| March 31, 2025 | -3.790B |
| December 31, 2024 | -634.20M |
| September 30, 2024 | -883.30M |
| June 30, 2024 | -646.50M |
| March 31, 2024 | -56.10M |
| December 31, 2023 | 54.70M |
| September 30, 2023 | 1.832B |
| June 30, 2023 | 1.854B |
| March 31, 2023 | 1.904B |
| December 31, 2022 | 2.079B |
| September 30, 2022 | 803.60M |
| June 30, 2022 | 760.80M |
| March 31, 2022 | 167.70M |
| December 31, 2021 | -1.269B |
| September 30, 2021 | -1.921B |
| June 30, 2021 | -2.047B |
| March 31, 2021 | -1.728B |
| December 31, 2020 | -669.90M |
| September 30, 2020 | 266.40M |
| June 30, 2020 | 270.50M |
| Date | Value |
|---|---|
| March 31, 2020 | 62.60M |
| December 31, 2019 | 16.80M |
| September 30, 2019 | 47.50M |
| June 30, 2019 | 34.40M |
| March 31, 2019 | 240.40M |
| December 31, 2018 | 352.50M |
| September 30, 2018 | 545.60M |
| June 30, 2018 | 457.20M |
| March 31, 2018 | 716.70M |
| December 31, 2017 | 696.00M |
| September 30, 2017 | 869.20M |
| June 30, 2017 | 661.10M |
| March 31, 2017 | 532.50M |
| December 31, 2016 | 480.00M |
| September 30, 2016 | 257.10M |
| June 30, 2016 | 805.50M |
| March 31, 2016 | 805.00M |
| December 31, 2015 | 847.70M |
| September 30, 2015 | 843.60M |
| June 30, 2015 | 914.40M |
| March 31, 2015 | 873.10M |
| December 31, 2014 | 933.10M |
| September 30, 2014 | 923.55M |
| June 30, 2014 | 583.57M |
| March 31, 2014 | 635.59M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (TTM) Benchmarks
| Pfizer Inc. | 4.373B |
| Eli Lilly & Co. | 26.71B |
| Merck & Co., Inc. | 3.169B |
| Bristol Myers Squibb Co. | 9.275B |
| Johnson & Johnson | 21.04B |